AvalonBay Communities, Inc. (NYSE:AVB) is one of the 10 Interest Rate Sensitive Stocks to Buy Now. On June 16, 2026, Truist raised its price target on AvalonBay Communities, Inc. (NYSE:AVB) to $202 from $201 and kept a Buy rating. Truist adjusted its model with expectations for 1.3% year-over-year same-store revenue growth in 2026 and 3.9% […]
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Markets have become increasingly sensitive to any headline that hints at government spending or political influence. Defense contractors, AI companies, and cybersecurity firms can all move sharply on a single news report, even when the underlying information isn’t actually new. That happened again today after CNBC reported that President Trump bought between $1 million and ... Axon Soars on Trump Stock Purchase Highlighting Insider Trading Issues
AI is supplanting the consumer as the driver of US economic growth.
The company hopes to obtain approval for its air taxi soon, and that would certainly be a game changer for the stock.
AbbVie (NYSE:ABBV) received positive opinions from the European Medicines Agency's CHMP for RINVOQ in severe alopecia areata and non-segmental vitiligo. If approved, RINVOQ could become the first systemic therapy for non-segmental vitiligo in Europe. The new indications target areas with high unmet medical need in dermatology and immunology. AbbVie has been active across immunology, gastroenterology and virology, and RINVOQ is already a core asset in its portfolio. These fresh CHMP...
A blockbuster deal positions the company to compete more directly with SpaceX.
TTM (TTMI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
RTX (RTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Chevron reached the market before ExxonMobil.
VICR's 621% surge reflects rising AI power demand, proprietary technologies, IP licensing growth and manufacturing leverage supporting long-term gains.
In the past five years, this top healthcare stock has risen by close to 130%.
Palo Alto Networks is expanding its AI security platform through partnerships that enhance cyber protection and target regulated industries.
JNJ gets a positive CHMP opinion for Tecvayli in combination with Darzalex SC for treating relapsed/refractory multiple myeloma after one prior therapy.
Strategy is scrambling to reassure investors amid a slump in the price of its primary means for funding crypto purchases.
Hub Group has been treading water for the past six months, holding steady at $43.74. The stock also fell short of the S&P 500’s 6.8% gain during that period.
Moderna stock soars on positive updates during the Science Day presentation. Jefferies sees significant further upside in MRNA shares.
The AI investment story has shifted repeatedly over the past year. Investors first piled into semiconductor companies, then power producers, networking firms, and data center infrastructure providers as the race to build AI capacity accelerated. Software companies, however, became the market’s biggest casualty after fears emerged that AI agents could replace many traditional software applications ... AI Didn’t Kill SaaS After All: Why Beaten-Down Software Stocks Are Rebounding
Ouster announced a string of partnerships and product launches this month that expand the use of its Rev8 digital lidar platform.
SYRE has surged on pipeline progress and a strong cash position, but with no product revenue and key trial data still ahead, is the risk already priced in?
AYI's Q3 beat, cash flow and AIS growth support the bull case, but valuation and lighting weakness keep the stock looking more like a hold.
Can EME's execution strength and record project pipeline outweigh FLR's expanding infrastructure opportunities?
BitMine Immersion Technologies continued adding to its Ethereum stockpile, even as its Bitcoin counterpart Strategy stood pat.
Investing.com -- Palantir Technologies Inc (NASDAQ:PLTR) is trading up 4.6% at $118.09 on Monday, extending a rebound that began Friday when the stock snapped a seven-session losing streak, after the company announced a strategic initiative with NVIDIA Corporation (NASDAQ:NVDA) to deploy open AI models inside classified and air-gapped government environments. The partnership pertains to a jointly developed intelligent engine pairing Nvidia's Blackwell Ultra GPUs and Nemotron open models with Pal
NVO and VKTX stocks offer contrasting opportunities in the fast-growing obesity market, with key differences in growth, risk and pipeline strength.
As of the end of last week, shares of Sandisk were up around 780%.
Shareholders of both Rocket Lab and Iridium Communications apparently see benefits to their combination.
SpaceX stock is losing momentum. But history might be warning investors to wait before they buy.
BJ's Restaurants (BJRI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.